Who is sponsoring NCT06031350?

NCT06031350 is sponsored by Omar Said.

What drugs are being tested in NCT06031350?

Interventions in NCT06031350: Optical Coherence Tomography Angiography.

What condition does NCT06031350 study?

NCT06031350 studies Non-arteritic Ischemic Optic Neuropathy.

Is NCT06031350 still recruiting?

NCT06031350 is currently completed. Last updated 11 September 2023.

Last reviewed 2023-09-11 · How we verify

NCT06031350

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Peripapillary and Macular Vascular Changes of Unilateral Anterior Ischemic Optic Neuropathy: An Optical Coherence Tomography Angiography Study

Completed Last updated 11 September 2023

What this trial tests

trial testing Optical Coherence Tomography Angiography in Non-arteritic Ischemic Optic Neuropathy in 30 participants. Completed in 30 June 2022.

Timeline

1 June 2021

Primary endpoint
31 May 2022

30 June 2022

Quick facts

Lead sponsor	Omar Said
Status	Completed
Study type	OBSERVATIONAL
Enrollment	30
Start date	1 June 2021
Primary completion	31 May 2022
Estimated completion	30 June 2022
Sites	1 location across Egypt

Drugs / interventions tested

Optical Coherence Tomography Angiography

Conditions studied

Non-arteritic Ischemic Optic Neuropathy — all drugs for Non-arteritic Ischemic Optic Neuropathy →

Sponsor

Omar Said

Who can join

Under 40, any sex, with Non-arteritic Ischemic Optic Neuropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This series aims at studying the peripapillary and macular vascular changes in subjects with unilateral anterior ischemic optic neuropathy via Optical Coherence Tomography Angiography (OCTA).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Optical Coherence Tomography Angiography

Trials testing the same drug.

NCT07060196 — The Impact of Artificial Lighting on the Visual Capacity of Patients With Age-Related Macular Degeneration · not yet recruiting
NCT04546997 — Study of Retinal Vascular Changes After Ocular Blunt Trauma · completed
NCT04443231 — Prospective Clinical Study of Retinal Microvascular Alteration After ICL Implantation · completed
NCT03635671 — Diabetic Retinopathy and Subclinical Signs of Disease Transition · terminated
NCT04217772 — OCTA Analysis In Children After Lensectomy · NA · unknown

Other Omar Said trials

Trials by the same sponsor.

NCT06000176 — Comparison of Optical Coherence Tomography Angiography Microvascular Changes in Primary Open Angle and Primary Angle Clo · completed
NCT06000150 — Characteristics of Trachomatous Corneal Opacity in Fayoum University Hospital · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06031350 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Omar Said
Last refreshed: 11 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06031350.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing